Even with modern biometry, advanced power-calculation formulas, and AI-assisted surgical planning, there is still a small but real chance of ending up with some residual refractive error after cataract or refractive lens exchange surgery — a bit of remaining nearsightedness or farsightedness, such as -1.00D or +1.00D, that wasn't fully eliminated by the initial lens choice. This risk is higher in eyes that are harder to predict, including those with prior LASIK or PRK, very high hyperopia, or unusually long or short eyeballs. The Light Adjustable Lens, or LAL, is a technology built specifically to address this problem — but it's also one of the more commonly misunderstood lens options, so it's worth being precise about what it does.
How it's different from a standard lens
With a standard intraocular lens, the surgeon calculates the needed power before surgery, based on measurements of the eye, and that power is fixed once the lens is implanted. If the post-operative result differs from the target, correcting it usually means glasses, contact lenses, or a further procedure.
The LAL takes a different approach. The surgeon still makes a best-estimate calculation and implants the lens, but the lens itself remains adjustable after surgery. During a series of follow-up visits, once the eye has healed enough for a stable, accurate refraction to be measured, the surgeon uses a special light treatment to non-invasively reshape the lens material and fine-tune its power based on the patient's actual measured outcome — not just the pre-operative estimate.
What it is not
This is the part that's often misunderstood: the LAL is fundamentally a monofocal lens. It can also be made in a toric version to correct astigmatism, but by itself it does not create an extended range of distance-to-near vision the way an EDOF or multifocal/trifocal lens does. Patients sometimes come away from a consultation with the impression that the LAL offers broad spectacle independence similar to a premium multifocal lens. That impression usually traces back to two real but more limited mechanisms:
Easier monovision trials. Because the lens power can be adjusted after healing, it becomes more practical to safely trial a monovision approach — optimizing one eye for distance and leaving the other intentionally slightly under-corrected for near — after surgery, rather than committing to it sight unseen beforehand. Monovision can genuinely reduce dependence on reading glasses for some patients, but it comes with the usual trade-offs: reduced depth perception compared to both eyes focused together, and an adjustment period that some patients don't get used to.
When the cataract still allows a meaningful trial, the same idea can often be simulated before surgery with contact lenses. This can be useful, but it is not workable for everyone: some people cannot tolerate contact lenses, and a visually significant cataract can make the result hard to interpret. Postoperative adjustment is therefore a distinctive advantage of the LAL, not the only possible way to test monovision.
Individual variation in depth of focus. Some patients' natural corneal aberration profile gives them a modest amount of extra depth of focus with any monofocal lens, including the LAL. This isn't a property unique to the LAL — it can happen with other monofocal or EDOF lenses too — and stretching depth of focus this way generally comes with a mild trade-off in contrast, similar to what happens with other lens designs that extend focal range.
Can the adjustment deliberately extend depth of focus?
In selected protocols, yes. A small prospective study showed that controlled negative spherical aberration and defocus could be induced in LAL eyes to improve intermediate and near vision; larger amounts also reduced monocular distance acuity. Response to induced spherical aberration varies between patients. This is a real but individualized optical strategy — not proof that the LAL becomes a trifocal lens or that every patient will gain the same visual range. Read the published study.
The bottom line
The LAL's genuine advantage is precision: the ability to fine-tune your final distance-vision prescription after your eye has fully healed, based on real measurements rather than a pre-operative estimate alone. That's a meaningful benefit, particularly for eyes that are harder to predict with standard formulas. But it is not a multifocal-equivalent lens, and patients shouldn't expect trifocal-like near vision from it on its own — that kind of outcome typically requires pairing it with a monovision strategy, discussed and planned together with your surgeon.
Postoperative adjustability primarily addresses uncertainty in the refractive target. It should not be confused with lens designs whose main purpose is to broaden intermediate vision. Direct head-to-head evidence comparing the LAL with modern enhanced monofocal lenses is limited, so it is not justified to assume that adjustability will always provide a broader or sharper baseline visual range. The choice depends on how much you value postoperative fine-tuning versus a lens design intended to extend range from the outset.
For more on how the LAL compares to other monofocal options, see the monofocal IOL overview, and for a broader framework on how to weigh lens categories against each other, see choosing an IOL.